TransCode Therapeutics In...
(RNAZ)
undefined
undefined%
At close: undefined
3.49
0.00%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -18.55M | -17.56M | -6.84M | -2.34M | -607.21K | -453.44K |
| Depreciation & Amortization | 516.75K | 98.61K | 42.47K | n/a | n/a | n/a |
| Stock-Based Compensation | 1.04M | 395.33K | 186.00K | 45.44K | 1.40K | 22.38K |
| Other Working Capital | -146.27K | -535.20K | -1.85M | 118.51K | 50.04K | 24.94K |
| Other Non-Cash Items | n/a | -890.95K | 39.47K | 1.50M | 102.01K | 106.55K |
| Deferred Income Tax | n/a | 890.95K | 876.19K | n/a | n/a | n/a |
| Change in Working Capital | -1.08M | 1.31M | 432.39K | 309.76K | -4.70K | 24.94K |
| Operating Cash Flow | -18.07M | -15.76M | -5.27M | -492.97K | -508.51K | -299.57K |
| Capital Expenditures | -35.61K | -100.92K | -254.82K | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | 3.00K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -100.92M | 3.00 | n/a | n/a | n/a |
| Investing Cash Flow | -35.61K | -100.92K | -251.82K | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 1.19M | 500.00K | 550.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 5.99K | -818.55K | -73.48K | n/a | -37.57K |
| Financial Cash Flow | 15.91M | 5.99K | 25.52M | 1.12M | 500.00K | 512.43K |
| Net Cash Flow | -2.20M | -15.86M | 20.00M | 623.54K | -8.51K | 212.86K |
| Free Cash Flow | -18.11M | -15.86M | -5.52M | -492.97K | -508.51K | -299.57K |